| __timestamp | Arrowhead Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 2026300000 |
| Thursday, January 1, 2015 | 34718089 | 2682700000 |
| Friday, January 1, 2016 | 40998209 | 2810000000 |
| Sunday, January 1, 2017 | 32022880 | 2582000000 |
| Monday, January 1, 2018 | 19110051 | 2473000000 |
| Tuesday, January 1, 2019 | 26556257 | 2554000000 |
| Wednesday, January 1, 2020 | 52275890 | 2367000000 |
| Friday, January 1, 2021 | 80981000 | 2624000000 |
| Saturday, January 1, 2022 | 124431000 | 2625000000 |
| Sunday, January 1, 2023 | 90932000 | 2917000000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc. over the past decade.
Bausch Health has consistently maintained high SG&A expenses, peaking at approximately $2.9 billion in 2023. This reflects their expansive operational scale and strategic investments in marketing and administration.
In contrast, Arrowhead Pharmaceuticals has shown a remarkable growth trajectory, with SG&A expenses increasing by over 300% from 2014 to 2024. This surge underscores their aggressive expansion and increased market presence.
While Bausch Health's expenses remain stable, Arrowhead's rapid increase highlights their dynamic growth strategy. Missing data for 2024 suggests potential shifts in Bausch Health's financial strategy.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.